These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11453711)

  • 21. What's the rush? Internal validity is not a trivial pursuit.
    Kovach CR
    Res Gerontol Nurs; 2010 Jan; 3(1):2-4. PubMed ID: 20128537
    [No Abstract]   [Full Text] [Related]  

  • 22. Mega-trials: methodological issues and clinical implications.
    Charlton BG
    J R Coll Physicians Lond; 1995; 29(2):96-100. PubMed ID: 7595900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.
    Braido F; Baiardini I; Compalati E; Bordo A; Canonica GW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):361-74. PubMed ID: 21659859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observational studies versus RCTs: what about socioeconomic factors?
    Rosén M; Axelsson S; Lindblom J
    Lancet; 2009 Jun; 373(9680):2026. PubMed ID: 19524779
    [No Abstract]   [Full Text] [Related]  

  • 25. The account for provider and center effects in multicenter interventional and surgical randomized controlled trials is in need of improvement: a review.
    Biau DJ; Porcher R; Boutron I
    J Clin Epidemiol; 2008 May; 61(5):435-9. PubMed ID: 18394535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodological advances and plans for improving regulatory success for confirmatory studies.
    Koch GG; Davis SM; Anderson RL
    Stat Med; 1998 Aug 15-30; 17(15-16):1675-90. PubMed ID: 9749439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical models appropriate for designs often used in group-randomized trials.
    Murray DM
    Stat Med; 2001 May 15-30; 20(9-10):1373-85. PubMed ID: 11343359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between rate of patient enrollment and quality of clinical center performance in two multicenter trials in ophthalmology.
    Hawkins BS; Prior MJ; Fisher MR; Blackhurst DW
    Control Clin Trials; 1990 Oct; 11(5):374-94. PubMed ID: 1963130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large-scale randomized evidence: large, simple trials and overviews of trials.
    Peto R; Collins R; Gray R
    J Clin Epidemiol; 1995 Jan; 48(1):23-40. PubMed ID: 7853045
    [No Abstract]   [Full Text] [Related]  

  • 30. Issues for statisticians in pharmaco-economic evaluations.
    Grieve AP
    Stat Med; 1998 Aug 15-30; 17(15-16):1715-23; discussion 1741-3. PubMed ID: 9749442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the causal structure of information bias and confounding bias in randomized trials.
    Shahar E; Shahar DJ
    J Eval Clin Pract; 2009 Dec; 15(6):1214-6. PubMed ID: 20367730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting on statistical methods to adjust for confounding: a cross-sectional survey.
    Müllner M; Matthews H; Altman DG
    Ann Intern Med; 2002 Jan; 136(2):122-6. PubMed ID: 11790063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TREAT: tamper-resistant envelope allocation technique for a multisite study.
    Sheeder J; Seale RA; Weber Yorga KD
    J Clin Epidemiol; 2016 Feb; 70():280-3. PubMed ID: 26415578
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostics for Confounding of Time-varying and Other Joint Exposures.
    Jackson JW
    Epidemiology; 2016 Nov; 27(6):859-69. PubMed ID: 27479649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.
    Trotta L; Kabeya Y; Buyse M; Doffagne E; Venet D; Desmet L; Burzykowski T; Tsuburaya A; Yoshida K; Miyashita Y; Morita S; Sakamoto J; Praveen P; Oba K
    Clin Trials; 2019 Oct; 16(5):512-522. PubMed ID: 31331195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The randomized clinical trial: beware of limitations.
    Singh K
    J Glaucoma; 2004 Apr; 13(2):87-9. PubMed ID: 15097251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.